Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
Crossref DOI link: https://doi.org/10.1007/s13300-020-00900-3
Published Online: 2020-08-07
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brooks, Anne B.
Langer, Jakob
Tervonen, Tommi
Peter Hemmingsen, Mads
Eguchi, Kosei
Bacci, Elizabeth D.
Text and Data Mining valid from 2020-08-07
Version of Record valid from 2020-08-07
Article History
Received: 21 July 2020
First Online: 7 August 2020